
Latest Perspectives



Every Heartbeat Counts: Take Action & Make an Impact This World Heart Day


The effectiveness of telemonitoring and integrated personalised diabetes management in people with insulin-treated type 2 diabetes mellitus


Chinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)


STRONG-HF: Enhancing GDMT regimen in Asia


Implementation of STRONG-HF protocol in heart failure management: an Australian perspective


Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China


Reshaping HF Management at NHCS


Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients


Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers


STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure


Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China


Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment


Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring


Heart Failure Management in India – Overcoming Present Challenges


STRONG-HF Trial highlighting benefits of treatment optimisation


STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management


Uncovering the Cardio-renal Risks of Chinese T2DM patients: Back to the Future with CUHK!


Management of Diabetes in Japan – Can Patients Play a More Significant Role?


T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP


Rapid algorithms for hs-cTn in ED: Boon or Bane?


2021 ESC Heart Failure Guidelines: What’s new?


Heart Failure in Hong Kong- Present Challenges and Future Strategies


Rapid Algorithms for Faster Triage of ED Patients with Suspected AMI – What Are We Waiting For?


Digital Prediction Platforms: A catalyst towards personalized CVD prognosis


CVD Management in T2DM – JCS and JDS Joint Consensus


ESC Recommendation: High sensitivity troponin assay vs conventional assay


ESC Recommendation: Rapid algorithms using hs troponin in ED


Setting sight on breakthrough diagnostics


Recommendations of IFCC on Natriuretic Peptide Testing


How to Implement ESC Rapid Algorithm Successfully?


The Changes in Rapid Algorithms for Acute Coronary Syndrome


Sex Differences in Troponin Levels – affecting high-sensitivity cardiac troponin (hs-cTn) levels


DAPA-HF and EMPEROR-Reduced Study Highlights


The role of biomarkers in HF


Digital health in HF management


Summary of APSC High Sensitivity Troponin T Consensus


APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19


Management of Cardiovascular Risks of COVID-19 Patients

